Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZNF512B Inhibitors

The class of compounds identified as ZNF512B inhibitors encompasses a diverse range of molecules that interact with various cellular mechanisms to modulate the activity of the zinc finger protein ZNF512B. These inhibitors are not a homogenous group but rather a collection of chemical entities that can influence the function of ZNF512B through different biochemical pathways. The inhibition of ZNF512B can occur through direct interactions with the protein itself or by altering the cellular context that regulates ZNF512B activity. For instance, some compounds in this class can affect the epigenetic markers on DNA or histones, thereby changing the chromatin landscape and accessibility of the transcription factor to its target genes. Others can interfere with signaling pathways that either activate or repress ZNF512B's function within the cell.

The diversity of the ZNF512B inhibitor class is further exemplified by the range of molecular targets they engage within the cell. Some members can affect post-translational modifications of proteins that are crucial for the proper localization, stability, or DNA-binding capacity of ZNF512B. Additionally, these compounds can influence upstream signaling molecules that regulate ZNF512B, thus modulating its activity indirectly. By targeting kinases or phosphatases that are part of these signaling cascades, ZNF512B inhibitors can alter the phosphorylation status of the protein or its cofactors, which in turn affects the function of ZNF512B. Other members of this class can modulate the proteostasis of ZNF512B by affecting the ubiquitin-proteasome system, thus affecting the turnover rate of the protein and its availability in the cell. Each member of the ZNF512B inhibitor class operates through distinct molecular mechanisms, reflecting the complexity of the cellular processes that govern the activity of transcription factors such as ZNF512B.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

As a histone deacetylase (HDAC) inhibitor, Trichostatin A increases the acetylation of histones, which could possibly inhibit ZNF512B by altering chromatin structure and accessibility.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

By inhibiting DNA methyltransferase, 5-Azacytidine reduces DNA methylation, which could possibly inhibit ZNF512B by affecting its DNA binding affinity or the expression of genes that regulate ZNF512B.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is a MEK inhibitor. If ZNF512B is regulated by the MAPK/ERK pathway, PD98059 could possibly inhibit ZNF512B by decreasing its activation.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 inhibits PI3K, potentially reducing AKT signaling. If ZNF512B is involved in AKT-regulated pathways, LY294002 could possibly inhibit ZNF512B's regulatory influence.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

Targeting p38 MAPK, SB203580 could possibly inhibit ZNF512B by altering the cellular stress response if ZNF512B is involved in these pathways.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

As a JNK inhibitor, SP600125 could possibly inhibit ZNF512B if the transcription factor's activity is modulated by JNK signaling.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, which can alter cell growth and proliferation. If ZNF512B functions within mTOR-regulated pathways, Rapamycin could possibly inhibit ZNF512B.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

As a proteasome inhibitor, Bortezomib could possibly inhibit ZNF512B by altering the degradation of ZNF512B itself or proteins that modulate its function.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$111.00
$357.00
8
(0)

Thalidomide alters protein degradation via the ubiquitin-proteasome system, which could possibly inhibit ZNF512B by affecting its stability or the stability of associated regulatory proteins.

Nutlin-3

548472-68-0sc-45061
sc-45061A
sc-45061B
1 mg
5 mg
25 mg
$62.00
$225.00
$779.00
24
(1)

Nutlin-3 inhibits MDM2, stabilizing p53. If ZNF512B is part of p53-regulated pathways, Nutlin-3 could possibly inhibit ZNF512B by affecting p53 activity.